Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Design Therapeutics, Inc. | StockGist | StockGist

Companies
DSGN
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings DSGNSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Design Therapeutics, Inc.

Filed Aug 28, 2025

Accepted Aug 27, 2025, 8:00 PM ET

CIK 0001807120

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Design Therapeutics, Inc.

Person Type

PN

CUSIP: 25056L103

Amendment History

2 filings

SCHEDULE 13G
Original
Viewing
Aug 28, 20250000902664-25-003881
SCHEDULE 13G/A
Amendment 1
Latest
Feb 17, 20260000902664-26-001131

Recent Filings

Design Therapeutics, Inc.4 days ago

Design Therapeutics, Inc.3 weeks ago

Design Therapeutics, Inc.3 weeks ago

Design Therapeutics, Inc.1 months ago

Design Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice